| 영문 | vaccine | 한글 | 백신 |
|---|---|---|---|
| 설명 | 전염병에 대하여 인공적으로 면역을 주기 위해 생체에 투여하는 항원의 하나. 병원체 및 독소에 대한 방어기구를 강화할 목적으로 사용되는 미생물제제를 말한다. 프랑스의 미생물학자 L. 파스퇴르에 의하여 제창된 용어로서, 어떤 감염증에 대하여 인공적으로 면역을 얻기 위하여 그 병원 미생물 또는 그 독소액에 적당한 조작을 가하여 만든 것을 말한다. |
||
| 영문 | whooping cough, pertussis | 한글 | 백일해 |
|---|---|---|---|
| 설명 | 이것은 주로 소아에서 백일해 균에 의해서 발생하는 상기도(위쪽의 기도를 말함. 즉 인두, 후두, 기관을 말함)감염증이다. 특징적인 갑작스런 큰 기침이 증상으로 나타난다. 치료는 항생제의 투여이며, 때로는 폐렴으로 발전하기도 한다. 현재 우리나라에서는 백일해에 대한 예방접종을 디프테리아(diphteria), 파상풍(tetanus)과 같이 실시하고 있다. |
||
| DPT | Demerol, Phenergan, and Thorazine; dermatopontin; dichotic pitch discrimination test; diphtheria-per... |
|---|---|
| DPTPM | diphtheria-pertussis-tetanus-poliomyelitis-measles [vaccine] |
| DTaP | diphtheria-tetanus-pertussis [vaccine] |
| DTP | diphtheria-tetanus-pertussis [vaccine]; distal tingling on percussion; Tinel's sign |
| HPV | Hemophilus pertussis vaccine; hepatic portal vein; human papillomavirus; human parvovirus; hypoxic p... |
| BPV | Bordatella pertussis vaccine |
|---|---|
| DTP | Diphtheria-tetanus-pertussis vaccine |
| PV | Pertussis vaccine |
| B.p. | Bordetella pertussis |
| DPT | Diphtheria Pertussis Tetanus |
| pertussis vaccine | A suspension of killed bordetella pertussis organisms, used for immunization against pertussis (whooping cough). It is generally used in a mixture with diphtheria and tetanus toxoids (dtp). There is an acellular pertussis vaccine prepared from the purified antigenic components of bordetella pertussis, which causes fewer adverse reactions than whole-cell vaccine and, like the whole-cell vaccine, is generally used in a mixture with diphtheria and tetanus toxoids. (12 Dec 1998) |
|---|
| diphtheria-tetanus-pertussis vaccine | A vaccine consisting of diphtheria toxoid, tetanus toxoid, and pertussis vaccine. It is usually given to infants three times at two-month intervals, generally at 2, 4, and 6 months of age. The vaccine protects against diphtheria, tetanus, and whooping cough. In most cases the vaccine causes only a temporary fever and discomfort, but in a few cases serious neurological side effects have been observed. (12 Dec 1998) |
|---|---|
| Bordetella pertussis | <bacteria> A small, aerobic, gram-negative bacillus, causative organism of whooping cough. Produces a variety of toxins including a dermonecrotising toxin, an adenyl cyclase, an endotoxin and pertussis toxin, as well as surface components such as fimbrial haemagglutinin. (18 Nov 1997) |
| pertussis | <infectious disease> An acute, highly contagious infection of the respiratory tract, most frequently affecting young children, usually caused by Bordetella pertussis, a similar illness has been associated with infection by B. Parapertussis and B. Bronchiseptica. It is characterised by a catarrhal stage, beginning after an incubation period of about two weeks, with slight fever, sneesing, running at the nose and a dry cough. In a week or two the paroxysmal stage begins, with the characteristic paroxysmal cough, consisting of a deep inspiration, followed by a series of quick, short coughs, continuing until the air is expelled from the lungs, the close of the paroxysm is marked by a long drawn, shrill, whooping inspiration, due to spasmodic closure of the glottis. This stage lasts three to four weeks, after which the convalescent stage begins, in which paroxysms grow less frequent and less violent and finally cease. Synonym: whooping cough. Origin: L. Tussis = cough (18 Nov 1997) |
| pertussis immune globulin | A sterile solution of globulin's derived from the plasma of adult human donors who have been immunised with pertussis vaccine; used both prophylactically and therapeutically. Synonym: pertussis immunoglobulin. (05 Mar 2000) |
| pertussis immunoglobulin | A sterile solution of globulin's derived from the plasma of adult human donors who have been immunised with pertussis vaccine; used both prophylactically and therapeutically. Synonym: pertussis immunoglobulin. (05 Mar 2000) |
| pertussis-like syndrome | <syndrome> A syndrome characterised by severe episodes of coughing resembling whooping cough (pertussis). (05 Mar 2000) |
| pertussis syndrome | <infectious disease> An acute, highly contagious infection of the respiratory tract, most frequently affecting young children, usually caused by Bordetella pertussis, a similar illness has been associated with infection by B. Parapertussis and B. Bronchiseptica. It is characterised by a catarrhal stage, beginning after an incubation period of about two weeks, with slight fever, sneesing, running at the nose and a dry cough. In a week or two the paroxysmal stage begins, with the characteristic paroxysmal cough, consisting of a deep inspiration, followed by a series of quick, short coughs, continuing until the air is expelled from the lungs, the close of the paroxysm is marked by a long drawn, shrill, whooping inspiration, due to spasmodic closure of the glottis. This stage lasts three to four weeks, after which the convalescent stage begins, in which paroxysms grow less frequent and less violent and finally cease. Synonym: whooping cough. Origin: L. Tussis = cough (18 Nov 1997) |
| pertussis toxin | <protein> Protein complex (ca 117 kD). An A B toxin, the active subunit is a single polypeptide 28 kD), the binding subunit a pentamer (two heterodimers, 23 + 11.7 kD, 11.7 + 22 kD and a monomer (9.3 kD) that binds the heterodimers). The active subunit ADP ribosylates the _ subunit of the inhibitory GTP-binding protein (Gi). Crucial to the pathogenicity of Bordetella pertussis, the causative agent of whooping cough. (18 Nov 1997) |
| pertussis toxins | <chemical> Any of various biologically active proteins or toxins elaborated by bordetella pertussis that cause the symptoms of whooping cough. Some activate pancreatic islets, others inhibit the adenylate cyclase cascade and some cause lymphocytosis. Chemical name: Toxins, pertussis (12 Dec 1998) |
| human pertussis immune serum | The sterile serum prepared from the pooled blood of healthy adult human beings who have received repeated courses of phase I pertussis vaccine; administered intravenously or intramuscularly for the prophylaxis or treatment of whooping cough. (05 Mar 2000) |
| acellular vaccine | <immunology, pharmacology, virology> Vaccine consisting of antigenic parts of cells. (13 Nov 1997) |
| adjuvant vaccine | A vaccine that contains an adjuvant; most often the antigen (immunogen) is included in a water-in-oil emulsion (Freund incomplete type adjuvant), or is adsorbed onto an inorganic gel (alum, aluminum hydroxide or phosphate). (05 Mar 2000) |
| aqueous vaccine | A vaccine having a liquid vehicle (e.g., physiological salt solution) as distinguished from an emulsion. (05 Mar 2000) |
| attenuated vaccine | Live pathogens that have lost their virulence but are still capable of inducing a protective immune response to the virulent forms of the pathogen, e.g., Sabin polio vaccine. (05 Mar 2000) |
| autogenous vaccine | A vaccine made from a culture of the patient's own bacteria. (05 Mar 2000) |
Synonyms : Vaccine, Pertussis
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|